- Home
- GHRS vs TALK Comparison
GHRS vs TALK Comparison
Compare GHRS & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GHRS | TALK |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | Ireland | United States |
| Employees | N/A | 521 |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 947.2M | 788.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GHRS | TALK |
|---|---|---|
| Price | $16.77 | $5.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $41.38 | $6.42 |
| AVG Volume (30 Days) | 140.6K | ★ 5.1M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $26.02 |
| Revenue Next Year | N/A | $21.24 |
| P/E Ratio | ★ N/A | $155.55 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $8.66 | $2.22 |
| 52 Week High | $19.51 | $5.20 |
Technical Indicators
Market Signals| Indicator | GHRS | TALK |
|---|---|---|
| Relative Strength Index (RSI) | 64.14 | 62.97 |
| Support Level | $12.34 | $4.59 |
| Resistance Level | $19.26 | $5.19 |
| Average True Range (ATR) | 0.79 | 0.02 |
| MACD | 0.34 | -0.03 |
| Stochastic Oscillator | 92.09 | 50.00 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About TALK Talkspace Inc.
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.